Please Note:
This profile was automatically generated using 11 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 11 references found on the Internet. This information has not been verified. Learn more...
View all 11 references Web References
-
1. European Society of Hypertension - About ESH - ESH Scientific Council
www.eshonline.org/about_esh/es - [Cached]Published on: 10/29/2007 Last Visited: 10/29/2007
Prof. Harry A.J. Struijker-Boudier Cardiovascular Research Institute Maastricht -
2. Newsletter December
www.meuse-rhine-journal.com/Ne - [Cached]Published on: 12/1/2000 Last Visited: 3/19/2008
Professor Struijker Boudier of the University of Maastricht is to be awarded a honorary doctorate by the University of Liège on March 21, 2001. The doctorate is for his entire scholarly oeuvre. Professor Struijker Boudier has been scientific director of the Cardiovascular Research Institute Maastricht (CARIM) and also co-director of the French DEA program on vascular biology at the University of Paris since 1999. In addition to his work at Maastricht University, Struijker Boudier is an editor and referee for various scholarly journals in medicine and he was made a member of the 'Hollandsche Maatschappij der Wetenschappen' (Dutch Association for Science) in 1998. Last year he was elected an International Fellow of the Council on High Blood Pressure Research of the American Heart Foundation. http://www.pers.unimaas.nl -
3. Incyte and CARIM Enter into Research Partnership to Study Cardiovascular Disease
order.genomesystems.com/compan - [Cached]Published on: 12/13/2000 Last Visited: 4/9/2003
"Treatments for cardiovascular disease are currently limited," said Harry A.J. Struijker Boudier, Scientific Director of CARIM. "Access to Incyte's integrated genomics platform, including gene expression information and advanced microarray technology, will further our understanding of the genetic basis of cardiovascular disease, and accelerate our efforts to identify effective approaches for the early diagnosis, prevention and treatment of cardiovascular disease."
CARIM is known internationally for its focus on innovative cardiovascular research, integrating knowledge from molecule to patient.
As part of its strategy to build partnerships with academic institutions, Incyte has entered into similar research alliances with Baylor College of Medicine, the Roy Castle International Centre for Lung Cancer Research and the Huntsman Cancer Institute at the University of Utah.

